Regulatory Strategy & Market Access
Regulatory strategy and evidence for biotech, pharma and device teams, planned alongside the reimbursement question from the start. We prepare the technical case; agencies and notified bodies decide.
What We Deliver
Regulatory Pathway Mapping
A written comparison of likely pathways for your product in the markets you name, with the evidence each one expects and the open questions to settle first.
Submission Evidence Planning
A plan listing the nonclinical, clinical and technical evidence a submission needs, with owners, gaps and sequence. We prepare strategy and technical documents; you file.
Biological Safety Evaluation
Risk-based biological evaluation plans, chemical characterization and toxicological risk assessment for devices, under the ISO 10993 series.
Clinical Evaluation Literature Review
Protocol-led literature searches, appraisal and state-of-the-art summaries that feed a clinical evaluation report for EU MDR devices.
Evidence for HTA and Payers
Evidence summaries and gap lists that show what a health technology assessment body or payer is likely to ask for, built from the published literature.
Real-World Evidence Landscape
A review of what real-world data and published studies already say about your product class, and where a new study would add evidence.
How We Work
Science-led advice, delivered virtually, with the limits stated up front.
Technical depth first
Our edge is the science: biomaterials, polymers, radiation processing, formulation, characterization and evidence synthesis. Regulatory and commercial work starts from the technical facts.
Defined deliverables
Your written quote sets out the question we’ll address, the materials we need, the agreed deliverables, the timeline, and the fee.
Clear boundaries
We prepare technical evidence and strategy. We do not certify, approve or give legal opinions. All work is delivered virtually, for clients worldwide.
Explore in depth
Biocompatibility
ISO 10993 biocompatibility support for medical device companies: biological evaluation plans, chemical characterization and toxicological risk assessment.
Learn moreClinical Evaluation
Clinical evaluation report support for EU MDR device makers: protocol-led literature review, state of the art, appraisal and equivalence analysis.
Learn moreTell Us the Product and the Market
Name the product, the markets and the regulatory question. We’ll follow up by email and prepare a written quote once the scope is clear.